3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Multiple Endocrine Neoplasia Type 1
1
Coronary Disease
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
evolocumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Coronary Disease
×
evolocumab
×
Clear all
NCT03872401
2025-11-10
VESALIUS-CV
Amgen
Phase 3
Completed
12,301 enrolled